WILLIAM F DOYLE Insider Trading for May 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WILLIAM F DOYLE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of WILLIAM F DOYLE for May 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 31 2019 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Option Exercise | A | 5.21 | 20,000 | 104,200 | 20,000 | |
May 31 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 53.10 | 1,900 | 100,881 | 894,563 | 896.5 K to 894.6 K (-0.21 %) |
May 10 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | A | 47.56 | 35,000 | 1,664,600 | 35,000 | |
May 10 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | A | 47.56 | 115,060 | 5,472,254 | 115,060 | |
May 10 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 47.37 | 31,460 | 1,490,386 | 896,463 | 927.9 K to 896.5 K (-3.39 %) |
May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 293,839 | |
May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 352,607 | |
May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 47.62 | 58,768 | 2,798,532 | 927,923 | 869.2 K to 927.9 K (+6.76 %) |
May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 47.52 | 32,218 | 1,531,032 | 869,155 | 901.4 K to 869.2 K (-3.57 %) |
May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 48.92 | 58,768 | 2,874,931 | 901,373 | 842.6 K to 901.4 K (+6.97 %) |
May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 47.67 | 32,098 | 1,530,112 | 842,605 | 874.7 K to 842.6 K (-3.67 %) |
May 07 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 411,375 | |
May 07 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 48.89 | 58,768 | 2,873,168 | 874,703 | 815.9 K to 874.7 K (+7.20 %) |
May 07 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 48.07 | 29,038 | 1,395,915 | 815,935 | 845 K to 815.9 K (-3.44 %) |
May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 470,143 | |
May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 528,911 | |
May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 44.60 | 58,768 | 2,621,053 | 844,973 | 786.2 K to 845 K (+7.47 %) |
May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 45.21 | 29,966 | 1,354,643 | 786,205 | 816.2 K to 786.2 K (-3.67 %) |
May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 43.28 | 58,768 | 2,543,479 | 816,171 | 757.4 K to 816.2 K (+7.76 %) |